What are the classifications and types of cutaneous markers of tuberculosis (TB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cutaneous Tuberculosis: Classification and Types

Cutaneous tuberculosis is classified into three main categories based on the source of infection: inoculation tuberculosis (exogenous), tuberculosis from an endogenous source (contiguous spread), and hematogenous tuberculosis (distant spread), with each category encompassing distinct clinical manifestations that vary in bacterial load and immune response. 1, 2

Primary Classification System

The most clinically useful classification divides cutaneous TB into multibacillary and paucibacillary forms based on bacterial load and immune status 3:

Multibacillary Forms (High Bacterial Load)

These occur in patients with poor cell-mediated immunity and contain numerous organisms 3:

  • Primary inoculation tuberculosis (tuberculous chancre): Small papules developing at the site of direct inoculation in previously unexposed individuals 1, 2
  • Scrofuloderma: Results from contiguous spread from underlying infected lymph nodes, bones, or joints, presenting as ulcers and sinus tracts 1, 2, 4
  • Tuberculosis verrucosa cutis: Warty, hyperkeratotic lesions occurring from exogenous reinoculation in previously sensitized individuals with moderate immunity 1, 2, 4
  • Orificial tuberculosis: Occurs in severely immunocompromised patients with advanced systemic disease 2

Paucibacillary Forms (Low Bacterial Load)

These occur in patients with robust cell-mediated immunity and contain few or no organisms 3:

  • Lupus vulgaris: The most common form, presenting as slowly progressive plaques with an "apple jelly" appearance on diascopy 1, 5, 4
  • Tuberculids (hypersensitivity reactions):
    • Lichen scrofulosorum: Small follicular papules 1, 4
    • Papulonecrotic tuberculid: Necrotic papules with central crusting 1, 4

Classification by Source of Infection

Exogenous Inoculation

Direct introduction of organisms through broken skin 2:

  • Primary inoculation tuberculosis (tuberculous chancre)
  • Tuberculosis verrucosa cutis

Endogenous (Contiguous) Spread

Extension from adjacent infected structures 2:

  • Scrofuloderma (most common endogenous form)
  • Lupus vulgaris (can also occur via this route)

Hematogenous Spread

Dissemination from distant foci 2:

  • Lupus vulgaris (most commonly via this route)
  • Acute miliary tuberculosis of the skin
  • Tuberculids

Critical Clinical Distinctions

True cutaneous tuberculosis caused by Mycobacterium tuberculosis must be distinguished from atypical mycobacterial infections, as treatment differs substantially 1:

  • True CTB: Responds to standard anti-tuberculous therapy (rifampicin, isoniazid, pyrazinamide, ethambutol) 1
  • Atypical mycobacterial infections: Mostly resistant to anti-tuberculous drugs and require specific antibiotics 1

Systemic Involvement

Approximately one-third of cutaneous tuberculosis cases are associated with systemic involvement, making recognition crucial for disease control 3. The presence of cutaneous lesions should prompt evaluation for pulmonary and extrapulmonary TB 3.

Common Pitfalls

Cutaneous TB can present with myriad atypical manifestations that mimic other conditions 5, 3:

  • Lupus vulgaris may resemble furuncles, psoriasis, or dermatitis 5
  • Scrofuloderma can present as simple tubercular ulcers 5
  • TB can mimic squamous cell carcinoma or present as sporotrichoid patterns 5
  • Histopathology may show nonspecific inflammation without classic granuloma formation, requiring PCR or monoclonal antibodies for diagnosis 2

Maintain a high index of suspicion in appropriate clinical settings, particularly in patients from endemic areas, immunocompromised individuals, or those with known TB exposure 2. When suspected, obtain biopsy for both culture and histopathology, and consider PCR amplification when cultures are negative 2.

References

Research

Cutaneous tuberculosis overview and current treatment regimens.

Tuberculosis (Edinburgh, Scotland), 2015

Research

Cutaneous Tuberculosis.

Microbiology spectrum, 2017

Research

Cutaneous tuberculosis. Part I: Pathogenesis, classification, and clinical features.

Journal of the American Academy of Dermatology, 2023

Research

Atypical presentations of cutaneous tuberculosis: Series of 10 cases.

The Indian journal of tuberculosis, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.